Rare diseases
Investigational molecules
Locations
Back to Finland26 clinical trials in Kokkola, Finland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FinlandKliinisetTutkimukset.fi(opens in a new tab)Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
FinlandEfficacy and safety of the investigational mRNA influenza vaccine gskvx000000077430 (drug combination) in adults ≥ 65 years
FinlandSafety of PF-07872412 versus 20‑valent pneumococcal conjugate vaccine in healthy infants for prevention of pneumococcal disease
FinlandA Study of Group B Streptococcus 6-Valent Polysaccharide Conjugate Vaccine in Healthy Pregnant Women and Their Infants
FinlandStudy on the Effects of Fluorouracil and Capecitabine in Patients with Metastatic Colorectal Cancer
FinlandStudy on Oral Prednisolone and Sucrose for Treating Wheezing Caused by Rhinovirus in Children Under 2 Years Old
FinlandFinlandStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
FinlandSafety and immune response of PF-07872412 compared with 20-valent pneumococcal conjugate vaccine for pneumococcal disease in healthy children and adolescents
FinlandFinlandStudy on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older
FinlandEfficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
FinlandThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on respiratory syncytial virus (RSV) and influenza prevention through innovative vaccine development. Studies aim to protect both vulnerable populations and healthy adults.
Multiple clinical trials evaluating both preventive measures and therapeutic interventions for respiratory infections.
Significant developments in preventing meningococcal and pneumococcal infections through advanced vaccine research, particularly focusing on pediatric populations.
Research emphasizes vaccine safety and immunogenicity in different age groups.
Comprehensive studies on Herpes Zoster and Cytomegalovirus prevention, exploring novel vaccine technologies including mRNA platforms.
Focus on developing long-lasting immunity and reducing disease burden in susceptible populations.
Innovative research investigating emergency interventions for acute myocardial infarction, including self-administered treatments.
Studies aim to improve outcomes in high-risk cardiac patients through rapid intervention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
